HRT Financial’s Incannex Healthcare Limited Common Stock IXHL Stock Holding History

HRT Financial’s Portfolio IXHL Stock Details IXHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-792	Closed	-$47K	–	2817
2024 Q3	$47K	Sell	792 -672	-46%	-$41.5K	﹤0.01%	2115
2024 Q2	$129K	Sell	1,464 -1,302	-47%	-$112K	﹤0.01%	1729
2024 Q1	$297K	Buy	+2,766	New	+$333K	﹤0.01%	1557

Other funds holding IXHL

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HRT Financial's IXHL Position: Q4 2024 in Review

HRT Financial sold out of Incannex Healthcare Limited Common Stock (IXHL) in Q4 2024, closing a stake of 792 shares — an estimated $47K sold.

HRT Financial first reported a position in IXHL in Q1 2024 and held it in 3 quarters. The position peaked at $297K in Q1 2024. 7 funds tracked by Wall St. Rank hold IXHL as of Q4 2024.

HRT Financial reported no remaining Incannex Healthcare Limited Common Stock position as of Q4 2024 after selling out during the quarter.
HRT Financial sold 792 Incannex Healthcare Limited Common Stock shares in Q4 2024, an estimated $47K.
HRT Financial first reported a position in Incannex Healthcare Limited Common Stock in Q1 2024 and held it in 3 quarters.
HRT Financial's Incannex Healthcare Limited Common Stock position peaked at $297K in Q1 2024.
7 funds tracked by Wall St. Rank held Incannex Healthcare Limited Common Stock as of Q4 2024.

Based on HRT Financial's 13F filing for Q4 2024, filed 14 Feb 2025.